ID

15393

Beschreibung

Transarterial Chemoembolization (TACE) Plus Sorafenib Versus TACE for Advanced Hepatocellular Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT02150317

Link

https://clinicaltrials.gov/show/NCT02150317

Stichworte

  1. 29.05.16 29.05.16 -
Hochgeladen am

29. Mai 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :


Keine Kommentare

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Advanced Hepatocellular Carcinoma NCT02150317

Eligibility Advanced Hepatocellular Carcinoma NCT02150317

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
male or female patients > 18 years and <=70 years of age.
Beschreibung

age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
at least 2 radiologic imaging showing characteristic features of hepatocellular carcinoma or cytologic/histologic evidence.
Beschreibung

hepatocellular carcinoma

Datentyp

boolean

Alias
UMLS CUI [1]
C2239176
tumor in liver and radiologically definable vascular invasion or extrahepatic metastasis.
Beschreibung

vascular invasion or extrahepatic metastasis

Datentyp

boolean

Alias
UMLS CUI [1]
C0521157
UMLS CUI [2]
C0474915
criteria of liver function: child a-b level, serum bilirubin ≤ 1.5 times the upper limit of normal value,alanine aminotransferase and aspartate aminotransferase ≤ 2 times the upper limit of normal value.
Beschreibung

child a-b level, serum bilirubin

Datentyp

boolean

Alias
UMLS CUI [1]
C4050412
UMLS CUI [2]
C0428441
no dysfunction in major organs; blood routine, kidney function, cardiac function and lung function are basically normal.
Beschreibung

major organs

Datentyp

boolean

Alias
UMLS CUI [1]
C0026766
hb ≥90g/l,white blood cell count ≥3.000 cells/mm³,platelets ≥80.000 cells/mm³
Beschreibung

white blood cell count

Datentyp

boolean

Alias
UMLS CUI [1]
C0023508
patients who can understand this trial and have signed informed consent
Beschreibung

informed consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients with apparent cardiac, pulmonary, cerebral and renal dysfunction, which may affect the treatment of liver cancer.
Beschreibung

Study Subject Participation Status

Datentyp

boolean

Alias
UMLS CUI [1]
C0525058
UMLS CUI [2]
C0009488
patients with a medical history of other malignant tumors
Beschreibung

Malignant Neoplasms

Datentyp

boolean

Alias
UMLS CUI [1]
C0006826
subjects participating in other clinical trials
Beschreibung

subjects participating in other clinical trials

Datentyp

boolean

Alias
UMLS CUI [1]
C2348568
liver function:child c
Beschreibung

Child-Pugh Class C

Datentyp

boolean

Alias
UMLS CUI [1]
C3831115
no pathological evidence of hepatocellular carcinoma.
Beschreibung

no pathological evidence of hepatocellular carcinoma.

Datentyp

boolean

Alias
UMLS CUI [1]
C0205469

Ähnliche Modelle

Eligibility Advanced Hepatocellular Carcinoma NCT02150317

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
age
Item
male or female patients > 18 years and <=70 years of age.
boolean
C0001779 (UMLS CUI [1])
hepatocellular carcinoma
Item
at least 2 radiologic imaging showing characteristic features of hepatocellular carcinoma or cytologic/histologic evidence.
boolean
C2239176 (UMLS CUI [1])
vascular invasion or extrahepatic metastasis
Item
tumor in liver and radiologically definable vascular invasion or extrahepatic metastasis.
boolean
C0521157 (UMLS CUI [1])
C0474915 (UMLS CUI [2])
child a-b level, serum bilirubin
Item
criteria of liver function: child a-b level, serum bilirubin ≤ 1.5 times the upper limit of normal value,alanine aminotransferase and aspartate aminotransferase ≤ 2 times the upper limit of normal value.
boolean
C4050412 (UMLS CUI [1])
C0428441 (UMLS CUI [2])
major organs
Item
no dysfunction in major organs; blood routine, kidney function, cardiac function and lung function are basically normal.
boolean
C0026766 (UMLS CUI [1])
white blood cell count
Item
hb ≥90g/l,white blood cell count ≥3.000 cells/mm³,platelets ≥80.000 cells/mm³
boolean
C0023508 (UMLS CUI [1])
informed consent
Item
patients who can understand this trial and have signed informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Study Subject Participation Status
Item
patients with apparent cardiac, pulmonary, cerebral and renal dysfunction, which may affect the treatment of liver cancer.
boolean
C0525058 (UMLS CUI [1])
C0009488 (UMLS CUI [2])
Malignant Neoplasms
Item
patients with a medical history of other malignant tumors
boolean
C0006826 (UMLS CUI [1])
subjects participating in other clinical trials
Item
subjects participating in other clinical trials
boolean
C2348568 (UMLS CUI [1])
Child-Pugh Class C
Item
liver function:child c
boolean
C3831115 (UMLS CUI [1])
no pathological evidence of hepatocellular carcinoma.
Item
no pathological evidence of hepatocellular carcinoma.
boolean
C0205469 (UMLS CUI [1])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video